Table 5.
Nanocomposites IC50 (μg/mL) | 3T3 Fibroblast cell | HepG2 cells |
---|---|---|
Sorafenib (SO) | N.C | 21.52 |
FPEG-MLDH | N.C | N.C |
FPVA-MLDH | N.C | N.C |
FPVASO-MLDH | N.C | 8.92 |
FPEGSO-MLDH | N.C | 15.15 |
Abbreviation: N.C, No toxicity at 100 µg/mL.
Nanocomposites IC50 (μg/mL) | 3T3 Fibroblast cell | HepG2 cells |
---|---|---|
Sorafenib (SO) | N.C | 21.52 |
FPEG-MLDH | N.C | N.C |
FPVA-MLDH | N.C | N.C |
FPVASO-MLDH | N.C | 8.92 |
FPEGSO-MLDH | N.C | 15.15 |
Abbreviation: N.C, No toxicity at 100 µg/mL.